Pancreatic Cancer Research

ResearcherWashington University in St. LouisActive in the last 2 years

Timothy J. Eberlein

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0008-7076-2357; OpenAlex author ID A5032371242; NIH RePORTER profile ID 1891624. Sources: OpenAlex.

Their work

Papers
1
Trials
0
Grants
1
Labs led
0
Collaborators
7
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 grant

Papers 1

  1. Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2/CCR2 axis. Co-author DOI 10.1158/1078-0432.ccr-13-0525↗

Grants 1

  1. 11 Solid Tumor Therapeutics Program P30CA091842↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Reid Townsend · 1 shared grant, 2026 · strength 1.00
  2. Christopher A Maher · 1 shared grant, 2026 · strength 1.00
  3. David C. Linehan · 1 shared paper, 2013 · strength 0.03
  4. Dominic E. Sanford · 1 shared paper, 2013 · strength 0.03
  5. Roheena Z. Panni · 1 shared paper, 2013 · strength 0.03
  6. Andrea Wang‐Gillam · 1 shared paper, 2013 · strength 0.03
  7. David G DeNardo · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.